Enovix (NASDAQ:ENVX) Releases Q3 2026 Earnings Guidance

Enovix (NASDAQ:ENVX – Get Free Report) updated its third quarter 2026 earnings guidance on Monday morning. The company provided EPS guidance of -0.140–0.140 for the period, compared to the consensus estimate of -0.160. The company issued revenue guidance of $11.0 million, compared to the consensus revenue estimate of $9.5 million.

Enovix Trading Down 3.1%

Shares of ENVX stock opened at $2.51 on Wednesday. The firm has a fifty day moving average of $3.29 and a 200-day moving average of $5.07. The stock has a market cap of $550.82 million, a price-to-earnings ratio of -3.10 and a beta of 2.49. Enovix has a 52-week low of $2.40 and a 52-week high of $14.21. The company has a debt-to-equity ratio of 2.46, a quick ratio of 9.37 and a current ratio of 9.71.

Get Enovix alerts:

Enovix (NASDAQ:ENVX – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The business had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 million. During the same period in the previous year, the business earned ($0.13) EPS. The firm’s revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts forecast that Enovix will post -0.80 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on ENVX. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 price target on shares of Enovix in a research note on Thursday, August 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a report on Friday, October 2nd. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research note on Sunday. Loop Capital upgraded Enovix to a “strong-buy” rating in a research report on Monday, August 17th. Finally, B. Riley Financial dropped their price objective on Enovix from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Enovix presently has an average rating of “Moderate Buy” and a consensus target price of $10.77.

View Our Latest Stock Analysis on Enovix

Enovix News Summary

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: New 100,000-battery drone order: Enovix received an initial purchase order from a multinational dual-use drone-system provider. Deliveries are scheduled for the first half of 2027 from its military-qualified, TAA-compliant South Korean facility, with potential follow-on orders later in 2027 and beyond. The order supports Enovix’s defense-market growth but has no disclosed dollar value. Enovix Receives 100,000-Battery Drone Order
• Positive Sentiment: Third-quarter revenue exceeded expectations: Preliminary Q3 2026 revenue was approximately $11 million, up 38% year over year and above the company’s $11 million guidance and roughly $9.5 million analyst consensus. The improvement was attributed partly to growing defense demand. Enovix Q3 Preliminary Revenue Rises 38%
• Positive Sentiment: Improved earnings outlook: Enovix guided to third-quarter EPS of approximately negative $0.14, better than the consensus estimate of negative $0.16. The company also raised confidence in its revenue trajectory. Enovix Q3 Revenue Rises 38% to $11 Million
• Neutral Sentiment: Analyst upside remains substantial: The reported average analyst price target is $11.77, well above recent trading levels. Targets are expectations rather than guarantees and depend on Enovix converting its pipeline into repeatable commercial revenue. Enovix Average Target Price
• Negative Sentiment: Profitability remains a concern: Enovix continues to report losses, and its preliminary guidance still implies negative EPS. The stock also remains highly volatile and below its longer-term moving averages, increasing sensitivity to execution, financing, and commercialization risks.

About Enovix

(Get Free Report)

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

Read More

• Five stocks we like better than Enovix
• A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
• Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
• Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
• Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.